Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Investments (2016 - 2019)

Immucell (ICCC) has disclosed Long-Term Investments for 6 consecutive years, with $4117.0 as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Long-Term Investments fell 95.69% year-over-year to $4117.0, compared with a TTM value of $4117.0 through Mar 2019, down 95.69%, and an annual FY2018 reading of $40209.0, down 57.92% over the prior year.
  • Long-Term Investments was $4117.0 for Q1 2019 at Immucell, down from $40209.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $489648.0 in Q4 2015 and bottomed at $4117.0 in Q1 2019.
  • Average Long-Term Investments over 5 years is $236376.1, with a median of $96973.5 recorded in 2017.
  • The sharpest move saw Long-Term Investments fell 1.28% in 2015, then crashed 95.69% in 2019.
  • Year by year, Long-Term Investments stood at $489648.0 in 2015, then fell by 0.54% to $487000.0 in 2016, then crashed by 80.38% to $95557.0 in 2017, then plummeted by 57.92% to $40209.0 in 2018, then crashed by 89.76% to $4117.0 in 2019.
  • Business Quant data shows Long-Term Investments for ICCC at $4117.0 in Q1 2019, $40209.0 in Q4 2018, and $98390.0 in Q3 2018.